NICHOLAS FERREIRA: Open Payments
NPI 1497197610 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 23 payments from 11 companies in 2025. Trend: 2023 $323 · 2024 $483 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $205 |
| E.R. Squibb & Sons, L.L.C. | 2 | $149 |
| ABBVIE INC. | 5 | $104 |
| Novo Nordisk Inc | 2 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| Corium, LLC | 1 | $26 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
Products named: REXULTI, COBENFY, VRAYLAR, Wegovy, Jornay PM, Auvelity, ARISTADA, ZEPBOUND.
Industry payments across MA — which companies pay providers there.
